Company Filing History:
5 out of 126 
1 out of 1 
1 out of 810 
Years Active: 2017-2024
Title: Orit Harari-Steinberg: Innovator in Cancer Treatment
Introduction
Orit Harari-Steinberg is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 5 patents, Harari-Steinberg is recognized for his work in targeting specific cancer-related proteins.
Latest Patents
Harari-Steinberg's latest patents include compositions targeting GABRA2 and methods for diagnosis and treatment of cancer. These patents provide methods for treating cancer in subjects by administering an effective amount of an agent that specifically binds to GABRA2. This agent may include a therapeutic moiety that downregulates the activity or expression of GABRA2. Additionally, his patents encompass compositions, articles of manufacture, and methods for diagnosing cancer and monitoring treatment. Another significant patent involves the identification of cancer stem cell markers in human primary tumors, which aids in diagnosis and treatment.
Career Highlights
Throughout his career, Harari-Steinberg has worked with various organizations, including Tel Hashomer Medical Research Infrastructure and Services Ltd. and Tageza Biopharmaceuticals Ltd. His work has been instrumental in advancing cancer research and treatment methodologies.
Collaborations
Harari-Steinberg has collaborated with notable colleagues, including Benjamin Dekel and Sanja Goldberg, who is a prominent female researcher in the field.
Conclusion
Orit Harari-Steinberg's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the medical research community. His work continues to pave the way for advancements in cancer diagnosis and therapy.